Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain
Clinical trial NCT02920528 · COMPLETED
Trial details
- NCT number
- NCT02920528
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-06-22
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.